Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
A Phase 1 Trial of MK-3475 Plus Ziv-Aflibercept in Patients With Advanced Solid Tumors
Sponsor: National Cancer Institute (NCI)
Listed as NCT02298959, this PHASE1 trial focuses on Clinical Stage IV Cutaneous Melanoma AJCC v8 and Metastatic Colorectal Carcinoma and remains ongoing. Sponsored by National Cancer Institute (NCI), it has been updated 60 times since 2015, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
60 versions recorded-
Mar 2026 — Present [monthly]
Active Not Recruiting PHASE1
-
Feb 2026 — Mar 2026 [monthly]
Active Not Recruiting PHASE1
-
Dec 2025 — Feb 2026 [monthly]
Active Not Recruiting PHASE1
-
Oct 2025 — Dec 2025 [monthly]
Active Not Recruiting PHASE1
-
Jun 2025 — Oct 2025 [monthly]
Active Not Recruiting PHASE1
▶ Show 55 earlier versions
-
May 2025 — Jun 2025 [monthly]
Active Not Recruiting PHASE1
-
Jan 2025 — May 2025 [monthly]
Active Not Recruiting PHASE1
-
Dec 2024 — Jan 2025 [monthly]
Active Not Recruiting PHASE1
-
Sep 2024 — Dec 2024 [monthly]
Active Not Recruiting PHASE1
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE1
-
Jul 2024 — Aug 2024 [monthly]
Active Not Recruiting PHASE1
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE1
-
Apr 2024 — Jun 2024 [monthly]
Active Not Recruiting PHASE1
-
Feb 2024 — Apr 2024 [monthly]
Active Not Recruiting PHASE1
-
Jan 2024 — Feb 2024 [monthly]
Active Not Recruiting PHASE1
-
Dec 2023 — Jan 2024 [monthly]
Active Not Recruiting PHASE1
-
Oct 2023 — Dec 2023 [monthly]
Active Not Recruiting PHASE1
-
Sep 2023 — Oct 2023 [monthly]
Active Not Recruiting PHASE1
-
May 2023 — Sep 2023 [monthly]
Active Not Recruiting PHASE1
-
Feb 2023 — May 2023 [monthly]
Active Not Recruiting PHASE1
-
Dec 2022 — Feb 2023 [monthly]
Active Not Recruiting PHASE1
-
Sep 2022 — Dec 2022 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Jul 2022 — Sep 2022 [monthly]
Recruiting PHASE1
-
May 2022 — Jul 2022 [monthly]
Recruiting PHASE1
-
Apr 2022 — May 2022 [monthly]
Recruiting PHASE1
-
Feb 2022 — Apr 2022 [monthly]
Recruiting PHASE1
-
Jan 2022 — Feb 2022 [monthly]
Recruiting PHASE1
-
Dec 2021 — Jan 2022 [monthly]
Recruiting PHASE1
-
Oct 2021 — Dec 2021 [monthly]
Recruiting PHASE1
-
Sep 2021 — Oct 2021 [monthly]
Recruiting PHASE1
-
Jun 2021 — Sep 2021 [monthly]
Recruiting PHASE1
-
Apr 2021 — Jun 2021 [monthly]
Recruiting PHASE1
-
Feb 2021 — Apr 2021 [monthly]
Recruiting PHASE1
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE1
-
Nov 2020 — Jan 2021 [monthly]
Recruiting PHASE1
-
Jul 2020 — Nov 2020 [monthly]
Recruiting PHASE1
-
Jun 2020 — Jul 2020 [monthly]
Recruiting PHASE1
-
May 2020 — Jun 2020 [monthly]
Recruiting PHASE1
-
Apr 2020 — May 2020 [monthly]
Recruiting PHASE1
-
Mar 2020 — Apr 2020 [monthly]
Recruiting PHASE1
-
Feb 2020 — Mar 2020 [monthly]
Recruiting PHASE1
-
Jan 2020 — Feb 2020 [monthly]
Recruiting PHASE1
-
Nov 2019 — Jan 2020 [monthly]
Recruiting PHASE1
-
Oct 2019 — Nov 2019 [monthly]
Recruiting PHASE1
-
Aug 2019 — Oct 2019 [monthly]
Recruiting PHASE1
-
May 2019 — Aug 2019 [monthly]
Recruiting PHASE1
-
Apr 2019 — May 2019 [monthly]
Recruiting PHASE1
-
Mar 2019 — Apr 2019 [monthly]
Recruiting PHASE1
-
Jan 2019 — Mar 2019 [monthly]
Recruiting PHASE1
-
Dec 2018 — Jan 2019 [monthly]
Recruiting PHASE1
Status: Suspended → Recruiting
-
Nov 2018 — Dec 2018 [monthly]
Suspended PHASE1
-
Oct 2018 — Nov 2018 [monthly]
Suspended PHASE1
-
Aug 2018 — Oct 2018 [monthly]
Suspended PHASE1
-
Jun 2018 — Aug 2018 [monthly]
Suspended PHASE1
-
Mar 2018 — Jun 2018 [monthly]
Suspended PHASE1
Status: Recruiting → Suspended
-
Dec 2017 — Mar 2018 [monthly]
Recruiting PHASE1
-
Aug 2017 — Dec 2017 [monthly]
Recruiting PHASE1
-
Jun 2017 — Aug 2017 [monthly]
Recruiting PHASE1
-
Feb 2017 — Jun 2017 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .